1. Home
  2. GTN vs ENTA Comparison

GTN vs ENTA Comparison

Compare GTN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GTN

Gray Television Inc.

N/A

Current Price

$4.55

Market Cap

432.5M

Sector

Industrials

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$12.56

Market Cap

377.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTN
ENTA
Founded
1897
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.5M
377.5M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
GTN
ENTA
Price
$4.55
$12.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$6.50
★ $21.83
AVG Volume (30 Days)
★ 872.2K
248.5K
Earning Date
11-06-2026
11-16-2026
Dividend Yield
★ 6.63%
N/A
EPS Growth
N/A
★ 29.93
EPS
★ N/A
N/A
Revenue
★ $3,095,000,000.00
$102,814,000.00
Revenue This Year
$17.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 16.48
52 Week Low
$3.55
$10.20
52 Week High
$6.44
$17.15

Technical Indicators

Market Signals
Indicator
GTN
ENTA
Relative Strength Index (RSI) 45.44 48.54
Support Level $4.47 $11.95
Resistance Level $4.70 $13.95
Average True Range (ATR) 0.16 0.57
MACD 0.01 0.02
Stochastic Oscillator 25.77 51.38

Price Performance

Historical Comparison
GTN
ENTA

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: